Miastenia Grave
DOI:
https://doi.org/10.34024/rnc.2005.v13.8805Palavras-chave:
suplementoResumo
.
Downloads
Métricas
Referências
Carandina-Maffeis R, et al. Plasmapheresis in the treatment of myasthenia gravis: retrospective study of 26 patients. Arq Neuropsiquiatr 2004;62: 391-395.
Dumitru D, Amato AA. Neuromuscular junction disorders. In: Dumitru D, Amato AA, Zwarts M (eds.). Electrodiagnostic medicine. 2ª ed. 2002, Filadelfia: Hanley & Belfus, 1127-1227.
Gronseth GS, Barohn RJ. Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review). Report of the quality standards subcommittee of the American Academy of Neurology. Neurology 2000; 55: 7-15.
Kesler KA, Wright CD, Loehrer PJ. Thymoma: current medical and surgical management. Semin Neurol 2004; 24:63-73.
Phillips II LH. The epidemiology of myasthenia gravis. Semin Neurol 2004; 24: 17-20.
Sieb JP. Myasthenia gravis: emerging new therapy options. Curr Opin Pharmacol 2005; 5:303-307.
Vernino S, Cheshire WP, Lennon VA. Myasthenia grave with autoimmune autonomic neuropathy. Auton Neurosci 2001; 88: 187-192.
Vincent A, et al. Seronegative myasthenia gravis. Semin Neurol 2004; 24:125-133.
Yonger DS, Engel AG, Sanders DB. Advances in diagnosis, pathogenesis and treatment of myasthenia gravis. Neurology 1997; 48 (supll 5):S1-S80.
Downloads
Publicado
Como Citar
Edição
Seção
Publicado: 2005-09-30
Português
English
Español
